Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Cleveland Clinic | United States

Author Profile

Orcid

Google Scholar

Early Academic Pursuits ๐ŸŽ“

Dr. Vishal Srivastavaโ€™s journey in academia began with a strong foundation in his chosen field of study. His passion for scientific exploration was evident from an early stage, as he pursued rigorous academic training. Excelling in his undergraduate and postgraduate studies, he displayed an exceptional ability to understand complex scientific concepts. His pursuit of higher education led him to specialize in cutting-edge research areas, setting the stage for his remarkable contributions to academia and industry.

Professional Endeavors ๐Ÿ’ผ

With a solid academic background, Dr. Vishal Srivastava embarked on a distinguished professional career, contributing his expertise to both academic institutions and research organizations. Over the years, he has taken on key roles that allowed him to bridge the gap between theoretical knowledge and practical applications. His leadership in various projects has been instrumental in shaping advancements within his domain, and his contributions continue to impact the scientific community.

Contributions and Research Focus ๐Ÿ”ฌ

Dr. Vishal Srivastava has dedicated his research efforts to groundbreaking studies that have significantly advanced knowledge in his field. His work spans multiple innovative areas, focusing on addressing real-world challenges through scientific inquiry and technological solutions. With a keen interest in emerging trends, he has contributed to numerous publications and research collaborations, further solidifying his reputation as a thought leader. His research findings have not only added to academic literature but have also been applied in practical scenarios, demonstrating the real-world relevance of his work.

Accolades and Recognition ๐Ÿ†

Dr. Vishal Srivastavaโ€™s contributions have been widely acknowledged, earning him prestigious accolades and recognitions from academic and professional organizations. His work has been featured in esteemed journals, and he has received awards for his pioneering research. These honors reflect his dedication, perseverance, and commitment to advancing knowledge in his field. His reputation as a scholar and innovator continues to grow as he receives invitations to share his insights at conferences, workshops, and industry events.

Impact and Influence ๐ŸŒ

Beyond his research and professional achievements, Dr. Vishal Srivastava has played a crucial role in mentoring young researchers and students. His guidance has inspired many to explore new ideas and push the boundaries of conventional knowledge. His contributions extend beyond academia, as he actively collaborates with industry partners to bring research-driven innovations into real-world applications. Through his work, he has influenced policies, technological developments, and scientific progress, leaving a lasting impact on the field.

Legacy and Future Contributions ๐Ÿš€

Dr. Vishal Srivastavaโ€™s legacy is one of innovation, excellence, and dedication to the pursuit of knowledge. As he continues his journey, he remains committed to pioneering research that addresses pressing global challenges. His future endeavors promise to bring further advancements, making significant contributions to science and technology. Through his ongoing work, he will continue to inspire future generations, shaping the future of research and innovation.

Publications


  •  ๐Ÿ“„Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion
    Journal: Biomolecules
    Year: 2025
    Authors: Vishal Srivastava, Zhigang Liu, Wei Wei, Yuan Zhang, James C. Paton, Adrienne W. Paton, Tingwei Mu, Bin Zhang


  •  ๐Ÿ“„ Mammalian Cargo Receptors for Endoplasmic Reticulum-to-Golgi Transport: Mechanisms and Interactions
    Journal: Biochemical Society Transactions
    Year: 2023
    Authors: Zhang Y, Srivastava V, Zhang B


  •  ๐Ÿ“„ The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota Transplanted Malnourished Gnotobiotic Pig Model
    Journal: mSphere
    Year: 2022
    Authors: Michael H, Srivastava V, Deblais L, Amimo JO, Chepngeno J, Saif LJ, Rajashekara G, Vlasova AN


  •  ๐Ÿ“„ Obese Children Gut Microbiota Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Renu S, Deblais L, Patil V, Schrock J, Kathayat D, Srivastava V, Feliciano-Ruiz N, Han Y, Ramesh A, Lakshmanappa Y S, Ghimire S, Dhakal S, Rajashekara G, Renukaradhya G J


  •  ๐Ÿ“„ Evaluation of Novel Quorum Sensing Inhibitors Targeting Autoinducer 2 (AI-2) for the Control of Avian Pathogenic Escherichia coli Infections in Chickens
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Helmy Y A, Kathayat D, Deblais L, Srivastava V, Closs G, Tokarski IIR J, Ayinde O, Fuchs J R, Rajashekara G


 

Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China                    

Author Profile

Orcid

Early Academic Pursuits ๐ŸŽ“

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors ๐Ÿ…

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus ๐Ÿ”ฌ

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

  • His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
  • He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
  • Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition ๐Ÿ†

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

  • National Encouragement Scholarship
  • Zhixing Scholarship for Postgraduate Students
  • Doctoral Research Incentive Scholarship
  • Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence ๐ŸŒ

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions ๐Ÿš€

Dr. Saxuโ€™s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

 

Publications


๐Ÿ“œ Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

  • Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

๐Ÿ“œ Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

  • Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

 

Gabriella Teresa Capolupo | Medicine and Dentistry | Best Research Award

Prof. Gabriella Teresa Capolupo | Medicine and Dentistry | Best Research Award

Fondazione Universitร  Campus Bio Medico di Roma | Italy

Author Profile

Scopus

Orcid

Early Academic Pursuits ๐ŸŽ“

Prof. Gabriella Teresa Capolupo's academic journey began with a Degree in Medicine and Surgery from the Faculty of Medicine of the Catholic University of the Sacred Heart of Milan - Rome branch in 2005, achieving a score of 110/110 cum laude. She registered in the Register of Surgeons of Rome in 2006, followed by obtaining a Specialist in General Surgery with honors in 2011. She pursued further specialization, earning a Doctorate in Endocrinology and Metabolic Diseases in 2016 and a Master's degree in Endocrinosurgery and Senology in 2023.

Professional Endeavors ๐Ÿฅ

Since 2012, Prof. Capolupo has held various positions at the University Polyclinic Campus Bio-Medico of Rome. Her roles have included managing professional functions in the Geriatric and Colorectal Surgery Units and conducting surgical interventions, primarily abdominal oncological surgeries, as the first operator, assistant, and assistant-guardian. She has also been actively involved in welfare activities and surgical on-call duties. In recent years, she has served as a Type A researcher with care duties at the Colorectal Surgery Unit and has been a teacher at the School of Specialization in General Surgery and Urology Specialization School.

Contributions and Research Focus ๐Ÿ”ฌ

Prof. Capolupo's research primarily focuses on general and colorectal surgery, with a particular interest in abdominal oncological surgery. Her dedication to research is evident through her involvement in the General Surgery Research Unit and her participation in welfare activities. She has also been a co-supervisor for numerous Master's theses, contributing to several significant publications in the field.

Accolades and Recognition ๐Ÿ†

Prof. Capolupo has received multiple recognitions throughout her career. In 2021, she won a competition for a researcher in general surgery type A. She achieved national scientific qualification for Professor II band in 2022 and has been a Fellow of the American College of Surgery since 2019. Additionally, she became a Fellow of the International College of Surgery in 2023 and has been an active member of several prestigious scientific societies.

Impact and Influence ๐ŸŒ

Prof. Capolupo's impact extends beyond her clinical and research work. She has been a significant contributor to the academic community as an editorial board member and reviewer for various scientific journals. Her influence is reflected in her bibliometric indices, with over 80 scientific publications, a h-index of 19, and 2315 citations as of July 2024. Her dedication to teaching and mentorship has shaped the careers of many students and professionals in the medical field.

Legacy and Future Contributions ๐Ÿ”ฎ

Prof. Capolupo's legacy is marked by her extensive contributions to surgical research and education. Her ongoing involvement in academic and clinical settings, coupled with her active participation in scientific societies, ensures her continued influence in the field. Her future contributions are expected to further advance the understanding and practice of general and colorectal surgery, benefiting both patients and the medical community at large.

 

Publications


๐Ÿ“œ Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis

๐Ÿ‘จโ€๐Ÿ”ฌ Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
๐Ÿ“˜ Journal: Special Issue Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery.
๐Ÿ“… Year: 2024


๐Ÿ“œ Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

๐Ÿ‘จโ€๐Ÿ”ฌ Authors: Bengueddach, A., Tidjane, A., Tabeti, B., Al-Hutheifi, R., Shream, S.
๐Ÿ“˜ Journal: British Journal of Surgery
๐Ÿ“… Year: 2024


๐Ÿ“œ Laparoscopic right hemicolectomy: a SICE (Societร  Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?โ€”CoDIG 2 (ColonDx Italian Group)

๐Ÿ‘จโ€๐Ÿ”ฌ Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
๐Ÿ“˜ Journal: Surgical Endoscopy
๐Ÿ“… Year: 2024


๐Ÿ“œ Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study

๐Ÿ‘จโ€๐Ÿ”ฌ Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
๐Ÿ“˜ Journal: British Journal of Surgery
๐Ÿ“… Year: 2024


๐Ÿ“œ Mechanical bowel preparation in elective colorectal surgery: a propensity score-matched analysis of the Italian colorectal anastomotic leakage (iCral) study group prospective cohorts

๐Ÿ‘จโ€๐Ÿ”ฌ Authors: Catarci, M., Guadagni, S., Masedu, F., Dalmonte, G., La Gioia, G.
๐Ÿ“˜ Journal: Updates in Surgery
๐Ÿ“… Year: 2024